NK cell receptor NKG2C deletion and HLA-E variants are risk factors for severe COVID-19
Hannes Vietzen(Medical University of Vienna), Elisabeth Puchhammer‐Stöckl(Medical University of Vienna), Stephan W. Aberle(Medical University of Vienna), Alexander Zoufaly(Kaiser-Franz-Josef-Spital), Judith H. Aberle(Medical University of Vienna), Marianna Traugott(Kaiser-Franz-Josef-Spital)
Cited by 8
Related Papers
Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis
|Cell|2023|170
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
|New England Journal of Medicine|2024|151
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
|The Lancet HIV|2018|145
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19
|Genetics in Medicine|2021|138
Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” study
|Alimentary Pharmacology & Therapeutics|2022|73